Drug intelligence / Profile preview

Qingrun

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Qingrun refers to a proprietary traditional Chinese medicine formula available in various forms, including capsules and pills, such as the Jinju Qingrun capsule and Qingrun Pills. It is commonly used in China for the treatment of conditions such as Sjogren’s syndrome, where it is administered to relieve symptoms like xerostomia (dry mouth) and dry eyes[4][5]. The composition typically involves herbal ingredients (specific composition is not provided in the current sources), and its mechanism of action is associated with the modulation of immune responses in autoimmune disorders, according to traditional Chinese medicine principles. It is orally administered and shows clinical benefit for symptom relief in Sjogren’s syndrome when used alone or in combination with conventional Western medicines[4]. There is no evidence of direct pharmaceutical mechanisms or molecular targets characteristic of modern pharmacological agents in the available literature.

Brand names
QingrunJinju Qingrun capsuleQingrun PillsJJQR
Other names
Jinju QingrunQingrun capsule
02

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on Qingrun.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingrun.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call